CVS Health makes board changes, drops three seats

Amy Baxter | | Health Exec | Management
meeting

CVS Health is changing up its board of directors, transitioning from 16 members to 13, according to an announcement. The move was “to further align with corporate governance best practices,” according to CVS.

Three current members––Richard “Dick” Swift, Richard Bracken and Mark Bertolini­­––will transition from their roles on the board of directors by not standing for reelection during CVS Health’s 2020 Annual Meeting.

“CVS Health is successfully executing against its strategy of becoming the world's most consumer-centric health care company,” Chair of the Board David W. Dorman said in a statement. “As the organization continues to evolve, the remaining directors of the Board and I have the utmost confidence in the strength of the current management team, the progress the company has shown to date and ability of CVS Health to deliver value to all stakeholders moving forward."

Swift was the former chair of the board and president and CEO of Foster Wheeler, a Swiss engineering company. He also served as a director of CVS Health since September 2006. Swift is retiring from the board after reaching the mandatory retirement age.

Bertolini, who was the former chairman and CEO of Aetna and became a director at CVS Health when the company merged with CVS Health at the end of 2018, will not continue as a board member after the 2020 meeting.

Bracken, former chairman and CEO of HCA and HCA Holdings, is retiring from the board after 45 years in healthcare. He has served as a director since Jan. 2015 and intends to spend more time on personal interests, according to the announcement.

"We want to thank each of these highly accomplished individuals for their service to the company and wish them all the best in the future,” Dorman said.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.